INS and glomerulosclerosis: Similar to erlotinib-treated eNOS–/–db/db and waved 2 eNOS–/–db/db mice, waved 1 mice crossed to eNOS–/–db/db mice also had marked decreases in gain of body weight, fasting blood glucose, islet macrophage infiltration, and glomerulosclerosis and preserved pancreatic insulin levels.